Rockwell Medical (NASDAQ:RMTI) is scheduled to release its earnings data after the market closes on Monday, May 17th. Analysts expect Rockwell Medical to post earnings of ($0.09) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
Rockwell Medical (NASDAQ:RMTI) last posted its earnings results on Tuesday, March 30th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.01). Rockwell Medical had a negative return on equity of 117.67% and a negative net margin of 47.23%. On average, analysts expect Rockwell Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of RMTI opened at $0.92 on Friday. The firm has a fifty day simple moving average of $1.01 and a two-hundred day simple moving average of $1.15. The firm has a market cap of $85.63 million, a PE ratio of -2.13 and a beta of 1.11. The company has a current ratio of 6.13, a quick ratio of 5.83 and a debt-to-equity ratio of 0.50. Rockwell Medical has a 1-year low of $0.83 and a 1-year high of $2.25.
Rockwell Medical Company Profile
Rockwell Medical, Inc operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis.
Featured Article: How to Use the MarketBeat Retirement Calculator
Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.